These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1380 related items for PubMed ID: 9679929

  • 1. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y, Yoshida O, Bonavida B.
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [Abstract] [Full Text] [Related]

  • 2. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin.
    Mizutani Y, Nakao M, Ogawa O, Yoshida O, Bonavida B, Miki T.
    J Urol; 2001 Jan; 165(1):263-70. PubMed ID: 11125422
    [Abstract] [Full Text] [Related]

  • 3. Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells.
    Mizutani Y, Yoshida O, Miki T, Bonavida B.
    Clin Cancer Res; 1999 Sep; 5(9):2605-12. PubMed ID: 10499639
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sensitization of human ovarian tumor cells by subtoxic CDDP to anti-fas antibody-mediated cytotoxicity and apoptosis.
    Uslu R, Jewett A, Bonavida B.
    Gynecol Oncol; 1996 Aug; 62(2):282-91. PubMed ID: 8751562
    [Abstract] [Full Text] [Related]

  • 7. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.
    Mizutani Y, Bonavida B, Koishihara Y, Akamatsu K, Ohsugi Y, Yoshida O.
    Cancer Res; 1995 Feb 01; 55(3):590-6. PubMed ID: 7834629
    [Abstract] [Full Text] [Related]

  • 8. Doxorubicin sensitizes human bladder carcinoma cells to Fas-mediated cytotoxicity.
    Mizutani Y, Okada Y, Yoshida O, Fukumoto M, Bonavida B.
    Cancer; 1997 Mar 15; 79(6):1180-9. PubMed ID: 9070496
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prognostic significance of soluble Fas in the serum of patients with bladder cancer.
    Mizutani Y, Yoshida O, Bonavida B.
    J Urol; 1998 Aug 15; 160(2):571-6. PubMed ID: 9679930
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide.
    Mizutani Y, Fukumoto M, Bonavida B, Yoshida O.
    Cancer; 1994 Nov 01; 74(9):2546-54. PubMed ID: 7923012
    [Abstract] [Full Text] [Related]

  • 13. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins.
    Morimoto H, Yonehara S, Bonavida B.
    Cancer Res; 1993 Jun 01; 53(11):2591-6. PubMed ID: 7684321
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Enhancement of the sensitivity of renal cell carcinoma cells to fas-mediated cytotoxicity and apoptosis by the selective cyclooxygenase-2 inhibitor JTE-522.
    Sato N, Mizutani Y, Li YN, Fujiwara J, Ishida H, Toiyama D, Abe K, Hayashi I, Nakanishi H, Kawauchi A, Miki T.
    Urol Int; 2010 Jun 01; 84(3):362-8. PubMed ID: 20389170
    [Abstract] [Full Text] [Related]

  • 17. Carboxyamido-triazole (CAI), a signal transduction inhibitor induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2.
    Perabo FG, Wirger A, Kamp S, Lindner H, Schmidt DH, Müller SC, Kohn EC.
    Anticancer Res; 2004 Jun 01; 24(5A):2869-77. PubMed ID: 15517890
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-alpha and cis-diamminedichloroplatinum.
    Uslu R, Bonavida B.
    Cancer; 1996 Feb 15; 77(4):725-32. PubMed ID: 8616765
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 69.